Taken together with the previous results showing that LRH1 drives liver cancer as described above [28, 32–35], we hypothesized that an aberrant hLRH1S510 phosphorylation (hLRH1pS510) affects the prognosis of HCC subjects. The gene discussed is NR5A2; the disease is hepatocellular carcinoma.